Indication
Acute Bacterial Skin and Skin Structure Infections (ABSSSI), Community-Acquired Bacterial Pneumonia (CABP).
Dosage and Administration
| Indications | Dose | Duration (Days) |
| Acute Bacterial Skin and Skin Structure Infections (ABSSSI) | 300 mg of Delaflox for Injection every 12 hours over 60 minutes by intravenous infusion. | 5 to 14 |
| Community-Acquired Bacterial Pneumonia (CABP) | 5 to 10 |
OR, AS DIRECTED BY PHYSICIAN.
Composition
Delaflox 300 mg IV Injection: Each vial contains 433 mg of Delafloxacin Meglumine as lyophilized powder equivalent to Delafloxacin INN 300 mg for reconstitution and further dilution before intravenous infusion. The lyophilized powder is a light yellow to tan cake, which may exhibit cracking and shrinkage and slight variation in texture and color